Success Story: Advancing Cell-Based Therapies and Drug Discovery: NIW Approval Secured for an Indian Biomedical and Translational Science Researcher
Client’s Testimonial: "Thank you very much for your support throughout the NIW process. I truly appreciate all your help and guidance. It was really a long wait, but I'm glad it was approved without needing to upgrade to premium processing.” On June 9th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the field of
Read more [...] 
